Action required: Please refresh your browser
We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.
More details about this topic are available here »
ContraVir Pharmaceuticals to Provide Corporate, Business and Clinical Updates | ||
By: Nasdaq / GlobeNewswire - 18 Jun 2018 | Back to overview list |
|
Conference Call and Live Audio Webcast Scheduled for June 25, 2018, 4:30 p.m. ET EDISON, N.J., June 18, 2018 (GLOBE NEWSWIRE) -- ContraVir Pharmaceuticals, Inc. (NASDAQ:CTRV), a biopharmaceutical company focused on the development and commercialization of therapeutic drugs for the treatment of hepatitis B virus (HBV), announced today that the company will host a conference call and live audio webcast on Monday, June 25, 2018 at 4:30 p.m. ET to discuss recent corporate, business and clinical updates. Conference Call Information: An audio webcast will be accessible via the Investors section of ContraVir’s website at http://ir.contravir.com/investor-relations. An archive of the webcast will remain available for 90 days beginning at approximately 5:30 p.m., ET on June 25, 2018. About ContraVir Pharmaceuticals For further information, please contact: |
||
|
||
Copyright 2018 Nasdaq / GlobeNewswire | Back to overview list |